NCT07485361

Brief Summary

The goal of this observational study is to learn whether functional near-infrared spectroscopy (fNIRS) can measure brain activity in healthy adults and in people with disorders of consciousness (DoC) in the neuro-intensive care unit (Neuro-ICU). DoC include conditions such as coma and minimally conscious state that occur after severe brain injury. These conditions make it difficult to assess a person's level of awareness because many clinical tests rely on observable behaviors such as speaking or moving, which are commonly impaired after brain injury. The main questions the study aims to answer are:

  • Can fNIRS detect changes in brain activity in healthy adults when they receive sensory stimulation or perform mental tasks?
  • Can the same fNIRS protocol be used in patients with disorders of consciousness in the Neuro-ICU to measure brain responses and determine whether the method is feasible in this clinical setting? The investigators will first study healthy adult volunteers to establish baseline brain responses and determine which tasks produce the most reliable signals. The protocol will then be applied to patients with disorders of consciousness admitted to the Neuro-ICU. Participants will take part in a single research session lasting about 30 to 45 minutes while wearing the lightweight fNIRS headband that measures brain oxygen levels using near-infrared light. During the session, participants will:
  • Wear a non-invasive fNIRS headband placed on the forehead
  • Receive gentle sensory stimulation (for example, compression devices on the legs or hands)
  • Listen to sounds or spoken sentences
  • Perform guided mental tasks such as imagining walking through their home or imagining moving a limb The study does not test a treatment and will not change medical care. The goal is to determine whether fNIRS can safely and reliably measure brain activity at the bedside and provide preliminary information that may help guide future research on improving the assessment of consciousness after brain injury.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started May 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
May 2026Dec 2026

First Submitted

Initial submission to the registry

March 16, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 20, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

June 8, 2026

Status Verified

June 1, 2026

Enrollment Period

7 months

First QC Date

March 16, 2026

Last Update Submit

June 4, 2026

Conditions

Keywords

Functional Near-Infrared SpectroscopyNeurocritical CareFunctional NeuroimagingNeuro Intensive Care UnitNeurovascular CouplingConsciousness Assessment

Outcome Measures

Primary Outcomes (1)

  • Task-evoked cortical hemodynamic response measured with functional near-infrared spectroscopy (fNIRS)

    Cortical hemodynamic responses measured using fNIRS, quantified as changes in oxygenated hemoglobin (HbO) and deoxygenated hemoglobin (HbR) during somatosensory and cognitive task paradigms relative to rest periods.

    During a single fNIRS recording session (approximately 20-48 minutes, depending on participant group)

Study Arms (2)

Healthy Control Participants

Healthy adult participants undergo functional near-infrared spectroscopy (fNIRS) monitoring during a series of sensory and cognitive paradigms to characterize baseline hemodynamic responses and establish reference patterns in individuals with intact cognition.

Other: Functional Near-Infrared Spectroscopy Monitoring

Patients with Disorders of Consciousness

Patients with disorders of consciousness (DoC) admitted to the neuro-intensive care unit undergo functional near-infrared spectroscopy (fNIRS) monitoring using the refined paradigm to evaluate feasibility and obtain preliminary observations of cortical hemodynamic responses in this population.

Other: Functional Near-Infrared Spectroscopy Monitoring

Interventions

Participants undergo functional near-infrared spectroscopy (fNIRS) monitoring while exposed to a structured series of passive sensory stimuli and guided mental tasks designed to engage different levels of cognitive processing. Paradigms include somatosensory stimulation, auditory processing, semantic language processing, spatial navigation imagery, and motor imagery. Hemodynamic responses are measured as changes in oxygenated and deoxygenated hemoglobin.

Healthy Control ParticipantsPatients with Disorders of Consciousness

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population includes two groups: healthy adult volunteers and patients with DoC admitted to the neuro-intensive care unit. Healthy participants will be recruited from the local community and university population to establish baseline fNIRS responses during sensory and cognitive paradigms. Patients with DoC will be recruited from the Neuro-ICU at the participating medical center and include individuals with impaired consciousness following acute brain injury who meet the study eligibility criteria.

You may qualify if:

  • Healthy Control Participants:
  • Age 18 years or older
  • Proficient in English language
  • Intact cognition
  • Montreal Cognitive Assessment (MoCA) score \> 26
  • DoC Patients:
  • Age 18 years or older
  • Proficient in English language
  • Surrogate decision maker available
  • Admission to the intensive care unit within 28 days
  • Documented Glasgow Coma Scale (GCS) score
  • Auditory Function subscale score ≥1 on the Coma Recovery Scale-Revised (CRS-R)

You may not qualify if:

  • Healthy Control Participants:
  • Known baseline hearing impairment without available hearing aids
  • Neurological or psychiatric history
  • DoC Patients:
  • Known baseline hearing impairment without available hearing aids
  • Inability to obtain informed consent
  • Extensive bilateral frontal injury on available imaging (CT/MRI)
  • Patients who have undergone craniectomy surgery
  • IV sedation in the past 24 hours
  • Absent auditory startle response (\<1 from Auditory Function subscale score of CRS-R)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA School of Nursing; Ronald Reagan Medical Center

Los Angeles, California, 90095, United States

RECRUITING

MeSH Terms

Conditions

Consciousness DisordersComaPersistent Vegetative StateBrain InjuriesBrain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersUnconsciousnessBrain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Central Study Contacts

Lauren H Furtick, MSN, RN, PhD Candidate

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 16, 2026

First Posted

March 20, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

June 8, 2026

Record last verified: 2026-06

Locations